SCHEMBL8343752

SCHEMBL8343752

Cc1c(C(=O)c2ccccc2)[nH]c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
HSD17B10 Q99714 3/20 0.56
MAPT P10636 4/20 0.52
HPGD P15428 3/20 0.52
USP2 O75604 1/20 0.52
HTT P42858 1/20 0.52
KDM4E B2RXH2 4/20 0.51
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
MAOA P21397 1/20 0.49
DAO P14920 1/20 0.49
DDO Q99489 1/20 0.49
AHR P35869 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
POLB P06746 1/20 0.47
LMNA P02545 1/20 0.47
FOLH1 Q04609 1/20 0.46
GAA P10253 1/20 0.46
GFER P55789 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2722021 0.89 ALDH1A1 (0.63) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL3174278 0.87 ALDH1A1 (0.51) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL29897041 0.85 ALDH1A1 (0.63) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL2399274 0.85 ALDH1A1 (0.63) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL9654119 0.83 KDM4E (0.57) ALDH1A1HSD17B10HPGDKDM4EMEN1
SCHEMBL28911042 0.82 KDM4E (0.51) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL7066817 0.81 ALDH1A1 (0.52) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL8346159 0.81 ALDH1A1 (0.51) ALDH1A1HSD17B10MAPTHPGDUSP2
SCHEMBL8806930 0.81 KDM4E (0.57) ALDH1A1HSD17B10MAPTHPGDKDM4E
SCHEMBL10704376 0.80 ALDH1A1 (0.61) ALDH1A1HSD17B10MAPTHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5981525-A FOR THERAPY OR PROPHYLAXIS OF OSTEOPOROSIS,TUMOURS, ULCERS, AUTOIMMUNE DISEASES, LIPIDEMIC DISORDERS, HYPERCHOLESTEROLEMIC AND ATHEROSCLEROTIC DISEASES, AIDS ALZHEIMER'S DISEASE SMITHKLINE BEECHAM CORPORATION (US) 1999-11-09 US disclosed
EP-0802902-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS Smithkline Beecham S.p.A. (IT) 1997-10-29 EP disclosed
WO-1996021644-A1 INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF OSTEOPOROSIS SMITHKLINE BEECHAM S.P.A. (IT) 1996-07-18 WO disclosed